Literature DB >> 26211927

Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.

R W J Meijers1, N H R Litjens1, D A Hesselink1, A W Langerak2, C C Baan1, M G H Betjes1.   

Abstract

Cytomegalovirus (CMV) infection profoundly affects the T cell compartment and is associated with alterations in T cell aging parameters and generation of cytotoxic CD4(+) CD28null T cells. Hence, the effect of a primary CMV infection post-kidney transplantation (KT) on the peripheral T cell compartment was examined. As aging parameters, we determined the T cell differentiation status, T cell receptor excision circle (TREC) content, CD31(+) naïve T cell numbers and relative telomere length (RTL) pre-KT and 12 months post-KT. CMV-seronegative KT recipients, receiving a kidney from a CMV-seropositive donor (D+/R-) were compared to D+/R+ KT recipients. Eleven out of the 22 D+/R- KT recipients had CMV viremia post-KT. They developed CMV-specific CD4(+) and CD8(+) T cells and their T cell compartment shifted towards a more differentiated memory phenotype with expansion of CD4(+) CD28null and CD8(+) CD28null cells. One year post-KT, the CD8(+) T cell count was almost doubled compared to nonviremic D+/R- and D+/R+ KT recipients. In addition, the RTL of the CD8(+) T cell was significantly lower and both the TREC content and CD31(+) naïve T cell numbers significantly decreased. Moreover, primary CMV infection was associated with a negative impact on glomerular filtration rate. In conclusion, primary CMV infection has a substantial impact on the number and phenotype of peripheral T cells and may negatively affect renal allograft function. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell biology; basic (laboratory) research/science; immunobiology; infection and infectious agents; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; kidney transplantation: living donor; thymus/thymic biology; viral: Cytomegalovirus(CMV)

Mesh:

Year:  2015        PMID: 26211927     DOI: 10.1111/ajt.13396

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  17 in total

1.  NK cell and Th17 responses are differentially induced in murine cytomegalovirus infected renal allografts and vary according to recipient virus dose and strain.

Authors:  Mao Li; Srinivasa Rao Boddeda; Bo Chen; Qiang Zeng; Trenton R Schoeb; Victoria M Velazquez; Masako Shimamura
Journal:  Am J Transplant       Date:  2018-05-07       Impact factor: 8.086

2.  Oral shedding of human herpesviruses in renal transplant recipients.

Authors:  Dmitry José de Santana Sarmento; Tânia Regina Tozetto-Mendoza; Laura Masami Sumita; Ligia Camara Pierroti; Débora Pallos; Rubens Caliento; Michelle Palmieri; Victor Adriano de Oliveira Martins; Marina Gallottini; Claudio Sergio Pannuti; Paulo Henrique Braz-Silva
Journal:  Clin Oral Investig       Date:  2017-07-01       Impact factor: 3.573

Review 3.  The impact of inflationary cytomegalovirus-specific memory T cells on anti-tumour immune responses in patients with cancer.

Authors:  Xiao-Hua Luo; Qingda Meng; Martin Rao; Zhenjiang Liu; Georgia Paraschoudi; Ernest Dodoo; Markus Maeurer
Journal:  Immunology       Date:  2018-09-10       Impact factor: 7.397

4.  CD4+ CD28-Negative Cells: Armed and Dangerous.

Authors:  N Murakami; L V Riella
Journal:  Am J Transplant       Date:  2016-02-01       Impact factor: 8.086

5.  Latency for cytomegalovirus impacts T cell ageing significantly in elderly end-stage renal disease patients.

Authors:  L Huang; A W Langerak; C C Baan; N H R Litjens; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2016-08-19       Impact factor: 4.330

6.  Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

Authors:  Birgit Sawitzki; Paul N Harden; Petra Reinke; Aurélie Moreau; James A Hutchinson; David S Game; Qizhi Tang; Eva C Guinan; Manuela Battaglia; William J Burlingham; Ian S D Roberts; Mathias Streitz; Régis Josien; Carsten A Böger; Cristiano Scottà; James F Markmann; Joanna L Hester; Karsten Juerchott; Cecile Braudeau; Ben James; Laura Contreras-Ruiz; Jeroen B van der Net; Tobias Bergler; Rossana Caldara; William Petchey; Matthias Edinger; Nathalie Dupas; Michael Kapinsky; Ingrid Mutzbauer; Natalie M Otto; Robert Öllinger; Maria P Hernandez-Fuentes; Fadi Issa; Norbert Ahrens; Christoph Meyenberg; Sandra Karitzky; Ulrich Kunzendorf; Stuart J Knechtle; Josep Grinyó; Peter J Morris; Leslie Brent; Andrew Bushell; Laurence A Turka; Jeffrey A Bluestone; Robert I Lechler; Hans J Schlitt; Maria C Cuturi; Stephan Schlickeiser; Peter J Friend; Tewfik Miloud; Alexander Scheffold; Antonio Secchi; Kerry Crisalli; Sang-Mo Kang; Rachel Hilton; Bernhard Banas; Gilles Blancho; Hans-Dieter Volk; Giovanna Lombardi; Kathryn J Wood; Edward K Geissler
Journal:  Lancet       Date:  2020-05-23       Impact factor: 202.731

7.  Protective Cytomegalovirus (CMV)-Specific T-Cell Immunity Is Frequent in Kidney Transplant Patients without Serum Anti-CMV Antibodies.

Authors:  Nicolle H R Litjens; Ling Huang; Burç Dedeoglu; Ruud W J Meijers; Jaap Kwekkeboom; Michiel G H Betjes
Journal:  Front Immunol       Date:  2017-09-12       Impact factor: 7.561

8.  End stage renal disease patients have a skewed T cell receptor Vβ repertoire.

Authors:  Ling Huang; Anton W Langerak; Ingrid L M Wolvers-Tettero; Ruud W J Meijers; Carla C Baan; Nicolle H R Litjens; Michiel G H Betjes
Journal:  Immun Ageing       Date:  2015-12-14       Impact factor: 6.400

Review 9.  Posttransplant Immune Activation: Innocent Bystander or Insidious Culprit of Posttransplant Accelerated Atherosclerosis.

Authors:  Didier Ducloux; Jamal Bamoulid; Thomas Crepin; Jean-Michel Rebibou; Cecile Courivaud; Philippe Saas
Journal:  Cell Transplant       Date:  2017-09       Impact factor: 4.064

10.  Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.

Authors:  María Iglesias-Escudero; Marco Antonio Moro-García; Raquel Marcos-Fernández; Alejandra García-Torre; Marta Elena Álvarez-Argüelles; María Luisa Suárez-Fernández; Pablo Martínez-Camblor; Minerva Rodríguez; Rebeca Alonso-Arias
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.